Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ADC Therapeutics SA | Director | Common Shares | 108K | $388K | $3.58 | Jun 13, 2025 | Direct |
Merus N.V. | Director | Share Option (right to buy) | 13.2K | $120K | $13.52 | May 22, 2025 | Direct |
Prelude Therapeutics Inc | Director | Director Stock Option (Right to Buy) | 38K | Jun 12, 2025 | Direct | ||
Kymera Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 25, 2025 | Direct |